| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
79,620,000 |
| Market
Cap: |
12.77(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.1604 - $0.1604 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Soleno Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare diseases. Co.'s primary candidate is Diazoxide Choline Extended Release tablets (DCCR), a once-daily oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
200,798 |
343,298 |
| Total Buy Value |
$0 |
$0 |
$1,160,431 |
$1,897,756 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
7 |
12 |
| Total Shares Sold |
1,129,833 |
1,419,857 |
1,419,857 |
2,030,451 |
| Total Sell Value |
$52,883,521 |
$62,474,611 |
$62,474,611 |
$63,437,018 |
| Total People Sold |
5 |
5 |
5 |
6 |
| Total Sell Transactions |
6 |
27 |
27 |
76 |
| End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Schuler Jack W |
10% Owner |
– – • |
2019-03-22 |
4 |
B |
$2.37 |
$350,155 |
I/I |
147,645 |
259,052 |
1.5 |
- |
|
| Schuler Jack W |
10% Owner |
– – • |
2019-03-21 |
4 |
B |
$2.32 |
$258,275 |
I/I |
111,407 |
111,407 |
1.5 |
- |
|
| Oracle Partners Lp |
10% Owner |
– – • |
2019-03-14 |
4 |
B |
$1.20 |
$158,313 |
I/I |
129,463 |
342,834 |
1.5 |
- |
|
| Oracle Partners Lp |
10% Owner |
– – • |
2019-03-14 |
4 |
B |
$1.20 |
$1,080 |
I/I |
900 |
2,520,246 |
1.42 |
- |
|
| Sinclair Andrew |
Director |
– • – |
2018-12-21 |
4 |
B |
$1.60 |
$7,470,835 |
I/I |
4,669,272 |
4,669,272 |
2.1 |
- |
|
| Schuler Jack W |
10% Owner |
– – • |
2018-12-21 |
4 |
B |
$1.61 |
$4,868,699 |
I/I |
3,031,002 |
4,550,678 |
1.5 |
- |
|
| Feinberg Larry N |
10% Owner |
– – • |
2018-12-19 |
4 |
B |
$1.61 |
$635,019 |
I/I |
395,330 |
329,158 |
1.5 |
- |
|
| Feinberg Larry N |
10% Owner |
– – • |
2018-12-19 |
4 |
B |
$1.61 |
$1,365,042 |
I/I |
849,805 |
2,519,346 |
1.5 |
- |
|
| Technology Partners Affiliates Vii Lp |
10% Owner |
– – • |
2018-09-13 |
4 |
S |
$2.00 |
$5,002 |
I/I |
(2,501) |
36,823 |
|
- |
|
| Technology Partners Affiliates Vii Lp |
10% Owner |
– – • |
2018-09-12 |
4 |
S |
$2.02 |
$16,786 |
I/I |
(8,301) |
36,889 |
|
- |
|
| Technology Partners Affiliates Vii Lp |
10% Owner |
– – • |
2018-09-11 |
4 |
S |
$2.05 |
$24,295 |
I/I |
(11,880) |
37,108 |
|
- |
|
| Mario Ernest |
Director |
– • • |
2018-06-13 |
4 |
A |
$2.04 |
$7,356 |
D/D |
3,606 |
475,324 |
|
- |
|
| Mario Ernest |
Director |
– • • |
2018-06-11 |
4 |
A |
$2.04 |
$11,229 |
D/D |
5,480 |
471,718 |
|
- |
|
| Mario Ernest |
Director |
– • • |
2018-06-08 |
4 |
A |
$2.04 |
$30,257 |
D/D |
14,803 |
466,238 |
|
- |
|
| Mario Ernest |
Director |
– • • |
2018-06-07 |
4 |
A |
$2.00 |
$9,234 |
D/D |
4,611 |
451,435 |
|
- |
|
| Mario Ernest |
Director |
– • • |
2018-06-05 |
4 |
A |
$2.05 |
$2,460 |
D/D |
1,200 |
446,824 |
|
- |
|
| Mario Ernest |
Director |
– • • |
2018-06-01 |
4 |
A |
$2.05 |
$2,665 |
D/D |
1,300 |
445,624 |
|
- |
|
| Mario Ernest |
Director |
– • • |
2018-05-31 |
4 |
A |
$2.05 |
$1,025 |
D/D |
500 |
444,324 |
|
- |
|
| Mario Ernest |
Director |
– • • |
2018-05-29 |
4 |
A |
$2.01 |
$1,005 |
D/D |
500 |
443,824 |
|
- |
|
| Mario Ernest |
Director |
– • • |
2018-05-25 |
4 |
A |
$2.05 |
$10,250 |
D/D |
5,000 |
443,324 |
|
- |
|
| Mario Ernest |
Director |
– • • |
2018-05-21 |
4 |
A |
$1.94 |
$58,470 |
D/D |
30,000 |
438,324 |
|
- |
|
| Mario Ernest |
Director |
– • • |
2018-05-18 |
4 |
A |
$1.90 |
$47,500 |
D/D |
25,000 |
408,324 |
|
- |
|
| Oracle Partners Lp |
10% Owner |
– – • |
2018-05-15 |
4 |
B |
$1.93 |
$2,841 |
I/I |
1,474 |
551,423 |
1.42 |
- |
|
| Technology Partners Affiliates Vii Lp |
10% Owner |
– – • |
2018-05-14 |
4 |
A |
$3.40 |
$906,413 |
I/I |
266,592 |
37,421 |
|
- |
|
| Vivo Ventures Fund V, L.p. |
10% Owner |
– – • |
2018-05-14 |
4 |
A |
$3.40 |
$924,093 |
I/I |
271,792 |
49,456 |
|
- |
|
386 Records found
|
|
Page 11 of 16 |
|
|
